Inherent Biosciences
Salt Lake City, US · Founded 2019 · Delaware corporation · 3 known investors
Inherent Biosciences uses AI to analyze epigenetic patterns in sperm to diagnose and predict fertility outcomes such as male infertility, sperm age, embryo quality, and azoospermia. Through its Path Fertility division, it markets a sperm testing product (SpermQT) for reproductive health, serving couples and clinicians.
Founders & leadership
AO
Andrew OlsonExecutive Officer
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$1.5MraisedMay 2023 · 12 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2023 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew OlsonExecutive Officer
- Amount sold
- $1.5M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.